S&P 500 · sector · 60 empresas
Acciones de Salud en el S&P 500
En sus últimos ejercicios fiscales, las empresas del sector sumaron unos ingresos de $3,66 B y un beneficio neto de $196 mil M (5,4% de los ingresos). La mayor por ingresos es UnitedHealth Group.
Ingresos combinados en el último ejercicio fiscal, 60 empresas
crecimiento mediano de los ingresos a 10 años (53 empresas)
Ingresos y beneficio neto combinados desde 2010
Los ingresos de las empresas con cifras de todos los años (48) pasaron de $980 mil M en 2010 a $3,33 B en 2025: 8,5% al año.
No se pudieron cargar los datos del gráfico. La tabla de abajo tiene las mismas cifras.
Empresas
| UnitedHealth Group | UNH | Managed Health Care | 2025 | $448 mil M | $12,1 mil M | 2,7% | 11,7% | 11,0% | 8,2% | $8,73 | 16 | −5,8% |
| McKesson | MCK | Health Care Distributors | 2026 | $403 mil M | $4,76 mil M | 1,2% | 11,1% | 7,8% | 14,7% | $3,17 | 13 | −46,7% |
| CVS Health | CVS | Health Care Services | 2025 | $402 mil M | $1,77 mil M | 0,4% | 8,4% | 10,1% | −11,3% | $2,66 | 0 | +12,9% |
| COR | Health Care Distributors | 2025 | $321 mil M | $1,55 mil M | 0,5% | 11,1% | 9,0% | — | $2,20 | 17+ | −10,4% | |
| Cigna | CI | Health Care Services | 2025 | $275 mil M | $5,96 mil M | 2,2% | 11,4% | 21,9% | 10,7% | $6,04 | 5 | +3,1% |
| CAH | Health Care Distributors | 2026 | $254 mil M | $1,71 mil M | 0,7% | 9,4% | 7,7% | 5,3% | $2,04 | 18+ | −28,2% | |
| ELV | Managed Health Care | 2025 | $199 mil M | $5,66 mil M | 2,8% | 10,3% | 9,7% | 10,4% | $6,84 | 14 | −17,7% | |
| CNC | Managed Health Care | 2025 | $195 mil M | −$6,67 mil M | −3,4% | 11,9% | 23,9% | — | — | — | +100,3% | |
| HUM | Managed Health Care | 2025 | $130 mil M | $1,19 mil M | 0,9% | 10,9% | 9,1% | 1,5% | $3,54 | 0 | −20,1% | |
| Johnson & Johnson | JNJ | Pharmaceuticals | 2025 | $94,2 mil M | $26,8 mil M | 28,5% | 2,7% | 3,0% | 7,2% | $5,14 | 18+ | −13,6% |
| HCA | Health Care Facilities | 2025 | $75,6 mil M | $6,78 mil M | 9,0% | 8,0% | — | 19,0% | $2,88 | 5 | −43,9% | |
| LLY | Pharmaceuticals | 2025 | $65,2 mil M | $20,6 mil M | 31,7% | 21,6% | 12,6% | 26,1% | $6,23 | 9 | −15,6% | |
| MRK | Pharmaceuticals | 2025 | $65 mil M | $18,3 mil M | 28,1% | 9,4% | 5,1% | 16,7% | $3,28 | 15 | −11,8% | |
| PFE | Pharmaceuticals | 2025 | $62,6 mil M | $7,77 mil M | 12,4% | 8,5% | 2,5% | 2,1% | $1,72 | 15 | −8,7% | |
| ABBV | Biotechnology | 2025 | $61,2 mil M | $4,23 mil M | 6,9% | 6,0% | 10,3% | −2,8% | $6,65 | 11 | +8,3% | |
| BMY | Pharmaceuticals | 2025 | $48,2 mil M | $7,05 mil M | 14,6% | 2,5% | 11,3% | 14,0% | $2,49 | 18+ | +21,4% | |
| TMO | Life Sciences Tools & Services | 2025 | $44,6 mil M | $6,7 mil M | 15,0% | 6,7% | 10,1% | 13,7% | $1,72 | 8 | −6,0% | |
| ABT | Health Care Equipment | 2025 | $44,3 mil M | $6,52 mil M | 14,7% | 5,1% | 8,1% | 2,5% | $2,40 | 3 | +16,1% | |
| AMGN | Biotechnology | 2025 | $36,8 mil M | $7,71 mil M | 21,0% | 7,6% | 5,4% | 4,6% | $9,66 | 12 | −29,2% | |
| MDT | Health Care Equipment | 2026 | $36,4 mil M | $4,8 mil M | 13,2% | 3,8% | 2,3% | 4,2% | $2,84 | 18+ | −9,7% | |
| Gilead Sciences | GILD | Biotechnology | 2025 | $29,4 mil M | $8,51 mil M | 28,9% | 3,6% | −1,0% | −5,5% | $3,16 | 10 | −17,5% |
| SYK | Health Care Equipment | 2025 | $25,1 mil M | $3,25 mil M | 12,9% | 11,8% | 9,7% | 8,3% | $3,40 | 16 | +1,5% | |
| DHR | Life Sciences Tools & Services | 2025 | $24,6 mil M | $3,61 mil M | 14,7% | 2,0% | — | 0,6% | — | — | +1,1% | |
| BDX | Health Care Equipment | 2025 | $21,8 mil M | $1,68 mil M | 7,7% | 6,3% | 7,8% | 5,7% | $4,16 | 12 | +39,0% | |
| GE HealthCare | GEHC | Health Care Equipment | 2025 | $20,6 mil M | $2,08 mil M | 10,1% | — | — | — | $0,14 | 2+ | — |
| BSX | Health Care Equipment | 2025 | $20,1 mil M | $2,9 mil M | 14,4% | 15,2% | 10,4% | — | — | — | +11,4% | |
| UHS | Health Care Facilities | 2025 | $17,4 mil M | $1,49 mil M | 8,6% | 8,5% | 6,7% | 13,1% | $0,80 | 0 | −36,0% | |
| IQV | Life Sciences Tools & Services | 2025 | $16,3 mil M | $1,36 mil M | 8,3% | 7,5% | 11,0% | 9,8% | — | — | +38,1% | |
| Regeneron Pharmaceuticals | REGN | Biotechnology | 2025 | $14,3 mil M | $4,5 mil M | 31,4% | 11,0% | 13,3% | 22,3% | $3,52 | 0 | −5,8% |
| VTRS | Pharmaceuticals | 2025 | $14,3 mil M | −$3,51 mil M | −24,6% | 3,7% | 4,3% | — | $0,48 | 0 | +134,6% | |
| Labcorp | LH | Health Care Services | 2025 | $14 mil M | $876M | 6,3% | −0,0% | 4,9% | 9,2% | $2,88 | 0 | −16,7% |
| DVA | Health Care Services | 2025 | $13,6 mil M | $747M | 5,5% | 3,4% | — | 22,9% | — | — | −64,9% | |
| Henry Schein | HSIC | Health Care Distributors | 2025 | $13,2 mil M | $398M | 3,0% | 5,4% | — | 1,4% | — | — | −27,7% |
| VRTX | Biotechnology | 2025 | $12 mil M | $3,95 mil M | 32,9% | 14,1% | 27,8% | — | — | — | +6,9% | |
| BAX | Health Care Equipment | 2025 | $11,2 mil M | −$957M | −8,5% | −0,7% | 1,2% | — | $0,52 | 0 | −6,6% | |
| Quest Diagnostics | DGX | Health Care Services | 2025 | $11 mil M | $992M | 9,0% | 3,2% | 3,9% | 6,0% | $3,20 | 15 | −22,1% |
| ISRG | Health Care Equipment | 2025 | $10,1 mil M | $2,86 mil M | 28,4% | 18,2% | 15,5% | 16,4% | — | — | +6,3% | |
| Biogen | BIIB | Biotechnology | 2025 | $9,89 mil M | $1,29 mil M | 13,1% | −6,0% | −0,8% | −5,4% | — | — | −36,4% |
| ZTS | Pharmaceuticals | 2025 | $9,47 mil M | $2,67 mil M | 28,2% | 7,2% | 7,1% | 24,4% | $2,03 | 12 | −11,6% | |
| SOLV | Health Care Technology | 2025 | $8,32 mil M | $1,56 mil M | 18,7% | — | — | — | — | — | — | |
| ZBH | Health Care Equipment | 2025 | $8,23 mil M | $705M | 8,6% | 6,1% | 3,2% | 16,5% | $0,96 | 0 | +4,7% | |
| A | Life Sciences Tools & Services | 2025 | $6,95 mil M | $1,3 mil M | 18,8% | 5,4% | 5,6% | 14,3% | $0,99 | 10 | −14,9% | |
| EW | Health Care Equipment | 2025 | $6,07 mil M | $1,07 mil M | 17,7% | 6,7% | 9,3% | 9,3% | — | — | −11,4% | |
| STE | Health Care Equipment | 2026 | $5,94 mil M | $782M | 13,2% | 13,8% | 10,2% | 17,7% | $2,46 | 15 | +38,7% | |
| RMD | Health Care Equipment | 2026 | $5,65 mil M | $1,52 mil M | 26,9% | 12,1% | 11,9% | 15,4% | $2,40 | 5 | +3,1% | |
| INCY | Biotechnology | 2025 | $5,14 mil M | $1,29 mil M | 25,0% | 14,0% | 21,2% | 71,0% | — | — | +7,2% | |
| Dexcom | DXCM | Health Care Equipment | 2025 | $4,66 mil M | $836M | 17,9% | 19,3% | 27,8% | — | — | — | +27,0% |
| ILMN | Life Sciences Tools & Services | 2025 | $4,34 mil M | $850M | 19,6% | 6,0% | 6,9% | 5,8% | — | — | +4,7% | |
| IDXX | Health Care Equipment | 2025 | $4,3 mil M | $1,06 mil M | 24,6% | 9,7% | 10,4% | 20,4% | — | — | −13,5% | |
| COO | Health Care Supplies | 2025 | $4,09 mil M | $375M | 9,2% | 11,0% | 8,6% | 6,1% | — | — | +1,6% | |
| ALGN | Health Care Supplies | 2025 | $4,03 mil M | $410M | 10,2% | 10,3% | 16,9% | 12,3% | — | — | −11,0% | |
| MTD | Life Sciences Tools & Services | 2025 | $4,03 mil M | $869M | 21,6% | 5,5% | 5,3% | 12,9% | — | — | −26,9% | |
| CRL | Life Sciences Tools & Services | 2025 | $4,02 mil M | −$144M | −3,6% | 6,5% | 11,4% | — | — | — | +4,1% | |
| VEEV | Health Care Technology | 2026 | $3,2 mil M | $909M | 28,4% | 16,9% | 22,8% | 30,5% | — | — | +15,2% | |
| Waters Corporation | WAT | Life Sciences Tools & Services | 2025 | $3,17 mil M | $643M | 20,3% | 6,0% | 4,5% | 6,7% | — | — | −28,1% |
| West Pharmaceutical Services | WST | Health Care Supplies | 2025 | $3,07 mil M | $494M | 16,1% | 7,4% | 8,2% | 18,0% | $0,86 | 17+ | −1,5% |
| RVTY | Health Care Equipment | 2025 | $2,86 mil M | $241M | 8,4% | 1,4% | 3,1% | 1,0% | $0,28 | 0 | +2,9% | |
| Insulet Corporation | PODD | Health Care Equipment | 2025 | $2,71 mil M | $247M | 9,1% | 24,5% | 26,2% | — | — | — | +26,6% |
| MRNA | Biotechnology | 2025 | $1,94 mil M | −$2,82 mil M | −145,2% | 19,3% | — | — | — | — | — | |
| Bio-Techne | TECH | Life Sciences Tools & Services | 2026 | $1,22 mil M | $182M | 15,0% | 5,5% | 9,3% | 5,2% | $0,32 | 0 | +5,2% |
Ingresos y beneficio neto: el último ejercicio fiscal (EF) completo. Crecimiento: tasa anual promedio a 5 o 10 años. Dividendo: por acción en el último año. Aumentos seguidos: años consecutivos de un dividendo por acción mayor; los datos de la SEC empiezan en 2009 (con 2007–2008 como años de comparación), así que + marca una racha que se remonta hasta donde empiezan las cifras de la empresa. Acciones, 10 años: variación del número de acciones; por debajo de cero significa recompras. —: no está en los datos o no es significativo.
Otros sectores
Fuente: SEC EDGAR (documentos de las empresas), datos a 13 de noviembre de 2026. Sectores, subindustrias, sedes y fechas de los índices: Wikipedia, CC BY-SA 4.0.